Cochrane Abstracts
Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Retinoic Acid Postconsolidation Therapy for High‐risk Neuroblastoma Patients Treated With Autologous Haematopoietic Stem Cell Transplantation." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439727/all/Retinoic_acid_postconsolidation_therapy_for_high‐risk_neuroblastoma_patients_treated_with_autologous_haematopoietic_stem_cell_transplantation_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed 23 April 2024.
Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439727/all/Retinoic_acid_postconsolidation_therapy_for_high‐risk_neuroblastoma_patients_treated_with_autologous_haematopoietic_stem_cell_transplantation_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed April 23, 2024.
Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439727/all/Retinoic_acid_postconsolidation_therapy_for_high‐risk_neuroblastoma_patients_treated_with_autologous_haematopoietic_stem_cell_transplantation_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Retinoic Acid Postconsolidation Therapy for High‐risk Neuroblastoma Patients Treated With Autologous Haematopoietic Stem Cell Transplantation [Internet]. In: Cochrane Abstracts. [cited 2024 April 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439727/all/Retinoic_acid_postconsolidation_therapy_for_high‐risk_neuroblastoma_patients_treated_with_autologous_haematopoietic_stem_cell_transplantation_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation
ID - 439727
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439727/all/Retinoic_acid_postconsolidation_therapy_for_high‐risk_neuroblastoma_patients_treated_with_autologous_haematopoietic_stem_cell_transplantation_New_search_for_studies_and_content_updated__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
